Oppenheimer Reiterates Outperform on Addus HomeCare, Maintains $118 Price Target
Portfolio Pulse from Benzinga Newsdesk
Oppenheimer analyst Michael Wiederhorn has reiterated an Outperform rating on Addus HomeCare (NASDAQ:ADUS) and maintained a price target of $118.
January 17, 2024 | 3:42 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Oppenheimer maintains an Outperform rating and a $118 price target for Addus HomeCare.
The reiteration of an Outperform rating by a reputable analyst like Michael Wiederhorn could instill confidence in investors and potentially lead to a positive short term impact on the stock price. The maintained price target of $118 suggests that the analyst believes the stock has room to grow, which could influence investor sentiment positively.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100